[go: up one dir, main page]

WO2009009769A3 - Diagnostic d'anomalies fœtales au moyen d'hématies nucléées - Google Patents

Diagnostic d'anomalies fœtales au moyen d'hématies nucléées Download PDF

Info

Publication number
WO2009009769A3
WO2009009769A3 PCT/US2008/069879 US2008069879W WO2009009769A3 WO 2009009769 A3 WO2009009769 A3 WO 2009009769A3 US 2008069879 W US2008069879 W US 2008069879W WO 2009009769 A3 WO2009009769 A3 WO 2009009769A3
Authority
WO
WIPO (PCT)
Prior art keywords
blood cells
red blood
diagnosis
nucleated red
fetal abnormalities
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2008/069879
Other languages
English (en)
Other versions
WO2009009769A2 (fr
Inventor
Ravi Kapur
Diana Bianchi
Tom Barber
Mehmet Toner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
General Hospital Corp
Tufts Medical Center Inc
Artemis Health Inc
Curate Biosciences LLC
Original Assignee
General Hospital Corp
Tufts Medical Center Inc
GPB Scientific Inc
Artemis Health Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by General Hospital Corp, Tufts Medical Center Inc, GPB Scientific Inc, Artemis Health Inc filed Critical General Hospital Corp
Publication of WO2009009769A2 publication Critical patent/WO2009009769A2/fr
Publication of WO2009009769A3 publication Critical patent/WO2009009769A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6841—In situ hybridisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/10—Investigating individual particles
    • G01N2015/1006—Investigating individual particles for cytology
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/10—Investigating individual particles
    • G01N2015/1029—Particle size
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/38—Pediatrics
    • G01N2800/385—Congenital anomalies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Urology & Nephrology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

La présente invention concerne des procédés de diagnostic d'une affection chez un fœtus par enrichissement et numération des hématies en circulation, éventuellement en association avec les résultats des criblages des marqueurs sériques maternels.
PCT/US2008/069879 2007-07-11 2008-07-11 Diagnostic d'anomalies fœtales au moyen d'hématies nucléées Ceased WO2009009769A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US94922707P 2007-07-11 2007-07-11
US60/949,227 2007-07-11

Publications (2)

Publication Number Publication Date
WO2009009769A2 WO2009009769A2 (fr) 2009-01-15
WO2009009769A3 true WO2009009769A3 (fr) 2009-04-09

Family

ID=40229506

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2008/069879 Ceased WO2009009769A2 (fr) 2007-07-11 2008-07-11 Diagnostic d'anomalies fœtales au moyen d'hématies nucléées

Country Status (1)

Country Link
WO (1) WO2009009769A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9163282B2 (en) 2010-05-18 2015-10-20 Natera, Inc. Methods for non-invasive prenatal ploidy calling

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004029221A2 (fr) 2002-09-27 2004-04-08 The General Hospital Corporation Dispositif microfluidique pour la separation de cellules et utilisations de ce dispositif
US9424392B2 (en) 2005-11-26 2016-08-23 Natera, Inc. System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals
US10083273B2 (en) 2005-07-29 2018-09-25 Natera, Inc. System and method for cleaning noisy genetic data and determining chromosome copy number
US11111544B2 (en) 2005-07-29 2021-09-07 Natera, Inc. System and method for cleaning noisy genetic data and determining chromosome copy number
US11111543B2 (en) 2005-07-29 2021-09-07 Natera, Inc. System and method for cleaning noisy genetic data and determining chromosome copy number
US10081839B2 (en) 2005-07-29 2018-09-25 Natera, Inc System and method for cleaning noisy genetic data and determining chromosome copy number
EP2589668A1 (fr) 2006-06-14 2013-05-08 Verinata Health, Inc Analyse de cellules rares utilisant la division d'échantillons et les marqueurs d'ADN
US20080050739A1 (en) 2006-06-14 2008-02-28 Roland Stoughton Diagnosis of fetal abnormalities using polymorphisms including short tandem repeats
CN104732118B (zh) 2008-08-04 2017-08-22 纳特拉公司 等位基因调用和倍性调用的方法
WO2010121294A1 (fr) * 2009-04-21 2010-10-28 Genetic Technologies Limited Procédés d'obtention de matériel génétique foetal
WO2011041485A1 (fr) 2009-09-30 2011-04-07 Gene Security Network, Inc. Méthode non invasive de détermination d'une ploïdie prénatale
US11939634B2 (en) 2010-05-18 2024-03-26 Natera, Inc. Methods for simultaneous amplification of target loci
US11332785B2 (en) 2010-05-18 2022-05-17 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US11408031B2 (en) 2010-05-18 2022-08-09 Natera, Inc. Methods for non-invasive prenatal paternity testing
US11339429B2 (en) 2010-05-18 2022-05-24 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US10316362B2 (en) 2010-05-18 2019-06-11 Natera, Inc. Methods for simultaneous amplification of target loci
US20190010543A1 (en) 2010-05-18 2019-01-10 Natera, Inc. Methods for simultaneous amplification of target loci
US12221653B2 (en) 2010-05-18 2025-02-11 Natera, Inc. Methods for simultaneous amplification of target loci
US11322224B2 (en) 2010-05-18 2022-05-03 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US9677118B2 (en) 2014-04-21 2017-06-13 Natera, Inc. Methods for simultaneous amplification of target loci
AU2011255641A1 (en) 2010-05-18 2012-12-06 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US12152275B2 (en) 2010-05-18 2024-11-26 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US11326208B2 (en) 2010-05-18 2022-05-10 Natera, Inc. Methods for nested PCR amplification of cell-free DNA
US11332793B2 (en) 2010-05-18 2022-05-17 Natera, Inc. Methods for simultaneous amplification of target loci
EP2656263B1 (fr) 2010-12-22 2019-11-06 Natera, Inc. Procédés de recherche de paternité prénatale, non invasive
US20140100126A1 (en) 2012-08-17 2014-04-10 Natera, Inc. Method for Non-Invasive Prenatal Testing Using Parental Mosaicism Data
CN103235133B (zh) * 2013-04-28 2014-11-19 成都中医药大学 一种胎儿9号染色体异常疾病的筛查试剂盒
CN103278633B (zh) * 2013-04-28 2014-11-19 成都中医药大学 一种孕妇流产史筛查试剂盒
US10262755B2 (en) 2014-04-21 2019-04-16 Natera, Inc. Detecting cancer mutations and aneuploidy in chromosomal segments
WO2015048535A1 (fr) 2013-09-27 2015-04-02 Natera, Inc. Normes d'essais pour diagnostics prénataux
US10577655B2 (en) 2013-09-27 2020-03-03 Natera, Inc. Cell free DNA diagnostic testing standards
CN113774132A (zh) 2014-04-21 2021-12-10 纳特拉公司 检测染色体片段中的突变和倍性
US20160130553A1 (en) 2014-05-15 2016-05-12 Kellbenx Incorporated PREPARATION OF FETAL NUCLEATED RED BLOOD CELLS (NRBCs) FOR DIAGNOSTIC TESTING
US20180173845A1 (en) 2014-06-05 2018-06-21 Natera, Inc. Systems and Methods for Detection of Aneuploidy
US12202890B1 (en) 2014-11-07 2025-01-21 Kellbenx Incorporated Antibodies for detection and enrichment of fetal cells and their use
DK3294906T3 (en) 2015-05-11 2024-08-05 Natera Inc Methods for determining ploidy
ES2913468T3 (es) 2016-04-15 2022-06-02 Natera Inc Métodos para la detección del cáncer de pulmón.
US11485996B2 (en) 2016-10-04 2022-11-01 Natera, Inc. Methods for characterizing copy number variation using proximity-litigation sequencing
GB201618485D0 (en) 2016-11-02 2016-12-14 Ucl Business Plc Method of detecting tumour recurrence
US10011870B2 (en) 2016-12-07 2018-07-03 Natera, Inc. Compositions and methods for identifying nucleic acid molecules
US10894976B2 (en) 2017-02-21 2021-01-19 Natera, Inc. Compositions, methods, and kits for isolating nucleic acids
US12084720B2 (en) 2017-12-14 2024-09-10 Natera, Inc. Assessing graft suitability for transplantation
US12398389B2 (en) 2018-02-15 2025-08-26 Natera, Inc. Methods for isolating nucleic acids with size selection
WO2019200228A1 (fr) 2018-04-14 2019-10-17 Natera, Inc. Procédés de détection et de surveillance du cancer au moyen d'une détection personnalisée d'adn tumoral circulant
US12234509B2 (en) 2018-07-03 2025-02-25 Natera, Inc. Methods for detection of donor-derived cell-free DNA
CN110093247B (zh) * 2019-05-07 2020-11-17 西安交通大学 一种富集捕获不同规格尺寸靶标细胞的微流控芯片
WO2020247263A1 (fr) 2019-06-06 2020-12-10 Natera, Inc. Procédés de détection d'adn de cellules immunitaires et de surveillance du système immunitaire
CN110471426B (zh) * 2019-09-02 2020-11-24 哈尔滨工程大学 基于量子狼群算法的无人驾驶智能车自动避碰方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070059716A1 (en) * 2005-09-15 2007-03-15 Ulysses Balis Methods for detecting fetal abnormality
US20070059719A1 (en) * 2005-09-15 2007-03-15 Michael Grisham Business methods for prenatal Diagnosis

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070059716A1 (en) * 2005-09-15 2007-03-15 Ulysses Balis Methods for detecting fetal abnormality
US20070059719A1 (en) * 2005-09-15 2007-03-15 Michael Grisham Business methods for prenatal Diagnosis

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
KRABCHI K. ET AL: "Quantification of all fetal nucleated cells in maternal blood in different cases of aneuploidies", CLINICAL GENETICS, vol. 69, 2006, pages 145 - 154 *
MAVROU A. ET AL: "Identification of nucleated red blood cells in maternal circulation: A second step in screening for fetal aneuploidies and pregnancy complications", PRENATAL DIAGNOSIS, vol. 27, 2007, pages 150 - 153 *
PERTL B. ET AL: "First trimester prenatal diagnosis: fetal cells in the maternal circulation", SEMINARS IN PERINATOLOGY, vol. 23, no. 5, October 1999 (1999-10-01), pages 393 - 402 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9163282B2 (en) 2010-05-18 2015-10-20 Natera, Inc. Methods for non-invasive prenatal ploidy calling

Also Published As

Publication number Publication date
WO2009009769A2 (fr) 2009-01-15

Similar Documents

Publication Publication Date Title
WO2009009769A3 (fr) Diagnostic d'anomalies fœtales au moyen d'hématies nucléées
EA201290716A1 (ru) Способы и композиции для неинвазивной пренатальной диагностики анеуплоидии плода
WO2012012703A3 (fr) Identification de régions génomiques fœtales ou maternelles différentiellement représentées et ses utilisations
WO2010078872A3 (fr) Enrichissement et identification de cellules foetales dans le sang maternel et ligands destinés à y être utilisés
EP2612928A3 (fr) Marqueurs pour le diagnostic et la surveillance prénatale
WO2005118852A3 (fr) Marqueur de diagnostic prenatal et de surveillance prenatale
WO2012177945A3 (fr) Méthodes de diagnostic pour œsophagite à éosinophiles
HK1206792A1 (en) Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses
IN2012DN03139A (fr)
WO2008014516A3 (fr) Sélection de cellules au moyen de biomarqueurs
EP2657697A3 (fr) Procédés de détermination du risque de complications dans un fétus
HK1208708A1 (en) Non-invasive method for detecting a fetal chromosomal aneuploidy
WO2007121276A3 (fr) Enrichissement d'adn foetal de circulation
WO2005035725A3 (fr) Methodes de diagnostic prenatal d'anomalies chromosomiques
WO2006034427A3 (fr) Diagnostic d'aneuploidie foetale
WO2008081451A3 (fr) Méthode et trousse d'analyse du matériel génétique d'un foetus
WO2007028155A3 (fr) Structure dimensionnelle de fragment d'adn foetal acellulaire du liquide amniotique pour le diagnostic prenatal
MXPA05010532A (es) Diagnostico genetico prenatal no invasivo usando celulas transcervicales.
WO2012088456A3 (fr) Procédés de recherche de paternité prénatale, non invasive
EP2963129A3 (fr) Marqueurs génétiques associés à l'autisme
American College of Obstetricians and Gynecologists Practice bulletin no. 166: thrombocytopenia in pregnancy
WO2010045611A3 (fr) Méthode pour diagnostiquer et surveiller l'activité d'une maladie et réponse à un traitement du lupus érythémateux systémique (sle) et d'autres maladies auto-immunes
WO2012081928A3 (fr) Procédé pour la détection de la méthylation du gène gpm6a marqueur de méthylation spécifique au cancer des intestins en vue du diagnostic du cancer des intestins
WO2007106838A3 (fr) Procédé non invasif permettant de diagnostiquer des cellules foetales et des cellules cancéreuses
WO2007126938A3 (fr) Marqueur d'anormalies chromosomiques

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08781738

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08781738

Country of ref document: EP

Kind code of ref document: A2